Overview
- 9 inspections across 8 sites are on record.
- 10 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-12.
At a glance
Inspections
9
Sites
8
Observations
10
Career since
Mar 2018
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Emergent BioSolutions Canada Inc. | 12 May 2026 | Biologics | View 483 → |
| Octapharma Produktionsgesellschaft Deutschland mbH | 11 Jun 2024 | Biologics | On file |
| Grifols Therapeutics LLC | 1 Sep 2023 | Biologics | On file |
| Octapharma Produktionsgesellschaft Deutschland mbH | 21 Mar 2023 | Biologics | On file |
| Octapharma Pharmazeutika Produktionsgesellschaft m.b.H. | 16 Dec 2022 | Biologics | On file |
Sites inspected
Emergent BioSolutions Canada Inc.Winnipeg, Canada1 insp.
Octapharma Produktionsgesellschaft Deutschland mbHSpringe, Germany2 insp.
Grifols Therapeutics LLCClayton, United States1 insp.
Octapharma Pharmazeutika Produktionsgesellschaft m.b.H.Vienna, Austria1 insp.
Co-investigators
Investigators who share inspections with this person.
Laura Fontan2 shared
Prabhu P Raju2 shared
Lewis K Antwi1 shared
Priscilla M Pastrana1 shared
Susan M Jackson1 shared
Zainab Y Mansaray-Storms1 shared
Kula N Jha1 shared
Bradley J Dworak1 shared
Roger F Zabinski1 shared
Mizanne E Lewis1 shared
Full investigator report
Get the verbatim findings behind Yonggang Wang's 10 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site